報價延遲最少15分鐘:2025/08/25 01:19 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.09 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.44/--
|
|
企業價值
116.32M
|
| 資產負債 |
|
每股賬面淨值
0.19
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
52.35M
|
|
每股收益
1.25
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/08/25 01:19 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue. |
